These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment]. Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532 [TBL] [Abstract][Full Text] [Related]
23. Zebrafish as a tool in Alzheimer's disease research. Newman M; Verdile G; Martins RN; Lardelli M Biochim Biophys Acta; 2011 Mar; 1812(3):346-52. PubMed ID: 20920580 [TBL] [Abstract][Full Text] [Related]
24. Transgenic mice as a model for Alzheimer's disease. Lithner CU; Hedberg MM; Nordberg A Curr Alzheimer Res; 2011 Dec; 8(8):818-31. PubMed ID: 21592052 [TBL] [Abstract][Full Text] [Related]
25. Rodent models for Alzheimer's disease drug discovery. Puzzo D; Gulisano W; Palmeri A; Arancio O Expert Opin Drug Discov; 2015 Jul; 10(7):703-11. PubMed ID: 25927677 [TBL] [Abstract][Full Text] [Related]
26. Mechanical stress models of Alzheimer's disease pathology. Levy Nogueira M; Epelbaum S; Steyaert JM; Dubois B; Schwartz L Alzheimers Dement; 2016 Mar; 12(3):324-33. PubMed ID: 26718585 [TBL] [Abstract][Full Text] [Related]
27. Review of Amyotrophic Lateral Sclerosis, Parkinson's and Alzheimer's diseases helps further define pathology of the novel paradigm for Alzheimer's with heavy metals as primary disease cause. Cavaleri F Med Hypotheses; 2015 Dec; 85(6):779-90. PubMed ID: 26604027 [TBL] [Abstract][Full Text] [Related]
34. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques. Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919 [TBL] [Abstract][Full Text] [Related]
35. Transgenic nonhuman primate models for human diseases: approaches and contributing factors. Chen Y; Niu Y; Ji W J Genet Genomics; 2012 Jun; 39(6):247-51. PubMed ID: 22749011 [TBL] [Abstract][Full Text] [Related]
36. Single and multiple transgenic mice as models for Alzheimer's disease. van Leuven F Prog Neurobiol; 2000 Jun; 61(3):305-12. PubMed ID: 10727777 [TBL] [Abstract][Full Text] [Related]
38. [Therapeutic strategies and Alzheimer's disease: contribution of animal models]. Chabrier PE Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893 [TBL] [Abstract][Full Text] [Related]
39. Commentary to the recently published review "Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease" by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116-40. Windisch M; Flunkert S; Havas D; Hutter-Paier B Ageing Res Rev; 2013 Sep; 12(4):852-4. PubMed ID: 23851053 [TBL] [Abstract][Full Text] [Related]
40. Using animal models to determine the significance of complement activation in Alzheimer's disease. Loeffler DA J Neuroinflammation; 2004 Oct; 1(1):18. PubMed ID: 15479474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]